Revolution Medicines, Inc. (1RVMD)
MTA
Closed
Aug 25, 2026
Day's Range
182.0552 wk Range
46.20Overview - 1RVMD - Revolution Medicines, Inc.
Key Statistics
Valuation
Enterprise Value
30.38B
P/E (Trailing)
‪-30.60‬
PEG Ratio
‪-0.22‬
Price / Book
‪17.17‬
EV / EBITDA
‪-21.97‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-30.12%‬
Return on Equity
‪-79.08%‬
Ownership
Shares Outstanding
214.24M
Float
184.45M
Held by Insiders
‪1.87%‬
Held by Institutions
‪100.99%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪162.93‬
200-Day Avg
‪111.08‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1RVMD - Revolution Medicines, Inc.
Peers - 1RVMD - Revolution Medicines, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1RVMDMTARevolution Medicines, Inc.12.75BMarket Cap+74.15%52-week change-30.04P/E (Trailing)‪0.00%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+27.69%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+44.44%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1RVMD - Revolution Medicines, Inc.
About
Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for cancers driven by the RAS protein, one of the most common cancer drivers affecting approximately 30% of human cancer diagnoses. Founded in 2014 and headquartered in Redwood City, California, the company applies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
